315 related articles for article (PubMed ID: 12175091)
21. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
[TBL] [Abstract][Full Text] [Related]
22. Reduced serum homocysteine levels in type 2 diabetes.
Mazza A; Bossone E; Mazza F; Distante A
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
[TBL] [Abstract][Full Text] [Related]
23. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
[TBL] [Abstract][Full Text] [Related]
24. Impact of renal function or folate status on altered plasma homocysteine levels in hypothyroidism.
Ozmen B; Ozmen D; Parildar Z; Mutaf I; Turgan N; Bayindir O
Endocr J; 2006 Feb; 53(1):119-24. PubMed ID: 16543681
[TBL] [Abstract][Full Text] [Related]
25. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
Soedamah-Muthu SS; Chaturvedi N; Teerlink T; Idzior-Walus B; Fuller JH; Stehouwer CD;
J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
[TBL] [Abstract][Full Text] [Related]
26. Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes.
Kassab A; Ajmi T; Issaoui M; Chaeib L; Miled A; Hammami M
Ann Clin Biochem; 2008 Sep; 45(Pt 5):476-80. PubMed ID: 18753419
[TBL] [Abstract][Full Text] [Related]
27. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C
Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
[TBL] [Abstract][Full Text] [Related]
28. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
29. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
Peczyńska J; Urban M; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
[TBL] [Abstract][Full Text] [Related]
30. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
[TBL] [Abstract][Full Text] [Related]
31. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
Banu N; Hara H; Egusa G; Yamakido M
Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
[TBL] [Abstract][Full Text] [Related]
32. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
[TBL] [Abstract][Full Text] [Related]
33. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance.
Veldman BA; Vervoort G; Blom H; Smits P
Diabet Med; 2005 Mar; 22(3):301-5. PubMed ID: 15717878
[TBL] [Abstract][Full Text] [Related]
34. Cystatin C as a marker of renal function in kidney transplant patients.
Mendiluce A; Bustamante J; Martin D; Santos M; Bustamante R; Pascual P; Jabary NS; Castañeda A; Muñoz MA
Transplant Proc; 2005 Nov; 37(9):3844-7. PubMed ID: 16386559
[TBL] [Abstract][Full Text] [Related]
35. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C.
Wasén E; Isoaho R; Mattila K; Vahlberg T; Kivelä SL; Irjala K
J Intern Med; 2004 Jul; 256(1):70-8. PubMed ID: 15189368
[TBL] [Abstract][Full Text] [Related]
36. Relationship between creatinine clearance and plasma homocysteine levels in predialytic chronic renal failure patients.
Widiana IG; Suwitra K
Acta Med Indones; 2004; 36(1):15-8. PubMed ID: 15931697
[TBL] [Abstract][Full Text] [Related]
37. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus.
Abdella NA; Mojiminiyi OA; Akanji AO; Moussa MA
Acta Diabetol; 2002 Dec; 39(4):183-90. PubMed ID: 12486492
[TBL] [Abstract][Full Text] [Related]
38. Can cystatin C be a better marker for the early detection of renal damage in primary hypertensive patients?
Ozer BA; Dursun B; Baykal A; Gultekin M; Suleymanlar G
Ren Fail; 2005; 27(3):247-53. PubMed ID: 15957539
[TBL] [Abstract][Full Text] [Related]
39. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
[TBL] [Abstract][Full Text] [Related]
40. Plasma homocysteine levels in children and adolescents with type 1 diabetes.
Atabek ME; Pirgon O; Karagozoglu E
Indian Pediatr; 2006 May; 43(5):401-7. PubMed ID: 16735761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
